Reportlinker finds all market research
reports published by official sources!
- Home
- Life Sciences
- Biotechnology
- Biological Therapy
- United States
- U.S. G-csf Sector Brief
U.S. G-csf Sector Brief
- This 10-page industry report was published in July 2011.
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
Talk to Sam
(866) 682 9815
Share
Biological Therapy Industry in the United States : Latest Downloads
Biological Therapy in India and The United States : Innovation and Technology Trends
- Industry report
- June 2012
- 30 pages
... It for phase iii clinical trials in india at 20 cancer centers. rnai based products will most likely be the first product to hit the market in the next 18-24 months with a high success rate and huge market ...
Biological Therapy in India and The United States : Innovation and Technology Trends
- Industry report
- June 2012
- 30 pages
... Split as a result of them being bought out by other major pharma companie. Benefits Besides colorectal cancer, rnai based products can also be used in the treatment of other types of cancer ...
Cell Therapy Business Brief
- Industry report
- October 2012
- 14 pages
... Cells image from the university of wisconsin-madison cardiovascular cell therapy research network (cctrn) 8 to promote and accelerate clinical research in the evaluation of novel cell therapy ...
Biological Therapy Industry Brief
9 months agoBiological Therapy : Innovation And Technolog ...
9 months agoBiological Therapy : Innovation And Technolog ...
11 months agoStem Cell : Innovation And Technology Trends
11 months agoBiological Therapy Business Brief
11 months agoBiological Therapy : Innovation And Technolog ...
12 months agoMore Reports:
Biological Therapy in China (5)
Biological Therapy Industry in the United States : Latest Reports
Multiple Myeloma (Kahler%s Disease) - Pipeline Review, H2 2012
- $ 2 500
- Industry report
- September 2012
- by Global Markets Direct
Multiple Myeloma (Kahler's Disease) - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Multiple Myeloma (Kahler's Disease) - Pipeline Review, H2 2012', provides an overview of the indication's ...
Amyloidosis - Pipeline Review, H2 2012
- $ 2 000
- Industry report
- September 2012
- by Global Markets Direct
Amyloidosis - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Amyloidosis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information ...
B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2012
- $ 2 500
- Industry report
- September 2012
- by Global Markets Direct
B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'B-Cell Non-Hodgkin Lymphoma - Pipeline Review, Global Markets Direct's, 'B-Cell Non-Hodgkin Lymphoma - Pipeline ...
Reportlinker.com © Copyright 2013. All rights reserved.
